N-cycloalkyl-substituted amino acids have wide-ranging applications in pharma-and nutraceutical fields. Here we report the asymmetric synthesis of various N-cycloalkylsubstituted L-aspartic acids using ethylenediamine-N,N'-disuccinic acid lyase (EDDS lyase) and a previously engineered variant of methylaspartate ammonia lyase (MAL-Q73A) as biocatalysts. Particularly, EDDS lyase shows broad non-natural substrate promiscuity and excellent enantioselectivity, allowing the selective addition of homo-and heterocycloalkyl amines (comprising four-, five-and six-membered rings) to fumarate, giving the corresponding N-cycloalkyl-substituted L-aspartic acids with >99% e.e. This biocatalytic methodology offers an alternative synthetic choice to prepare difficult N-cycloalkylsubstituted amino acids. Given its very broad amine scope, EDDS lyase is an exceptionally powerful synthetic tool that nicely complements the rapidly expanding toolbox of biocatalysts for asymmetric synthesis of noncanonical amino acids.
N-substituted L-aspartic acids are noncanonical amino acids that have wide applications in pharma-and nutraceutical fields, serving as drug candidates and chiral building blocks for pharmaceutically active molecules, artificial sweeteners and peptido-mimetics. [1] [2] [3] [4] [5] [6] [7] Therefore, the development of methodologies for the efficient synthesis of N-substituted aspartic acids in enantioenriched form is of high academic and industrial interest. The most common chemocatalytic synthetic strategy is the Michael addition of suitable amines to maleic acid, fumaric acid, their ester or amide derivatives, or monoalkali salts. [7] [8] [9] However, in these chemocatalytic reactions, racemic product mixtures are obtained. To achieve the desired single L-enantiomer, purification or resolution is needed, leading to unsatisfactory product yields lower than 50%.
Asymmetric hydroamination of alkenes is a desirable atom-economic route to introduce nitrogen-based functionalities into organic molecules. [10] [11] [12] Enzymatic addition of ammonia or amines to appropriate α,β-unsaturated mono-or dicarboxylic acids using C-N lyases as biocatalysts has become an attractive methodology to synthesize chiral α-amino acids, such as phenylalanine and aspartic acid, and their derivatives (Scheme 1). [10, [13] [14] [15] This enzymatic strategy employs readily available α,β-unsaturated acids as starting materials, escaping steps of protecting/activating carboxylic groups by derivatization as the corresponding esters or amides, and normally gives high stereocontrol under mild and potentially green reaction conditions. Using this concept, a range of N-substituted L-aspartic acids has previously been prepared. [16] [17] [18] For instance, aspartate ammonia lyase (AspB) from Bacillus sp. YM55-1 and methylaspartate ammonia lyase (MAL) from Clostridium tetanomorphum were found to accept several small substituted amines, like hydroxylamine, methoxylamine and methylamine, as substrates for hydroamination of fumarate or mesaconate, yielding the corresponding N-substituted L-aspartic acid derivatives. [16, 17] MAL is a homodimeric protein that belongs to the enolase superfamily, and exploits a deamination mechanism that involves general-base catalyzed formation of an enolate anion (aci-carboxylate) intermediate that is stabilized by coordination to the essential active site Mg 2+ ion. [14] The detailed knowledge of the structure and catalytic mechanism of MAL served as a guide to expand the synthetic usefulness of this enzyme by protein engineering. [19] Two variants of MAL were generated, one having an enlarged nucleophile scope (MAL-Q73A) and the other having an enlarged electrophile scope (MAL-L384A). [19] Using MAL-Q73A, a large variety of N-substituted Laspartic acids were synthesized with high enantioselectivity (>99% e.e.). [20] Structural analysis of MAL-Q73A showed that this mutant enzyme has an enlarged amine binding pocket, without changes in the orientation of active site residues, thus rationalizing its ability to convert the new amine substrates. [19] Recently, we reported another C-N lyase, ethylenediamine-N,N'-disuccinic acid (EDDS) lyase from Chelativorans sp. BNC1, that can catalyze the reversible addition of ethylene diamine to two molecules of fumarate to produce (S,S)-EDDS, which is an attractive biodegradable metal-chelator. [21] Wild-type EDDS lyase has a large amine scope, including linear mono-and diamines, and its preparative usefulness was recently demonstrated in the chemoenzymatic synthesis of aspergillomarasmine A (AMA), an important metallo-β-lactamase inhibitor, as well as various related aminocarboxylic acids. [22] Scheme 1. Direct hydroamination of α,β-unsaturated carboxylic acids catalyzed by a C-N lyase with enantiocontrol to synthesize optically pure α-amino acids.
Cycles are versatile and important structural moieties present in organic molecules, which act as good modifiers of properties and biological activities. [23] [24] [25] [26] Functionalization of amino acids with cycles is a subject of great interest, leading to a diversity of useful noncanonical amino acids with broad applications. [27] [28] [29] Here we report the asymmetric synthesis of various N-cycloalkyl-substituted L-aspartic acids using MAL-Q73A and EDDS lyase as biocatalysts. This biocatalytic methodology provides an alternative synthetic choice to prepare difficult Ncycloalkyl-substituted amino acids.
Previous work from our group demonstrated that the Q73A mutant of MAL exhibits an expanded amine scope, accepting various structurally distinct amines in hydroamination reactions. [19, 20] This prompted us to first test the potential of MAL-Q73A for the asymmetric synthesis of N-cycloalkyl-substituted L-aspartic acids. Out of ten amines tested, MAL-Q73A only accepted amines 2b, 2e and 2f as substrates (Table 1) . However, the observed conversions for the reactions with cycloalkyl amines 2b, 2e and 2f were quite low (20-25%). The enzymatic products 3b, 3e, and 3f were purified and identified as the corresponding Nsubstituted aspartic acid derivatives by 1 H NMR, 13 C NMR and HRMS (see Supporting Information).
As MAL-Q73A showed a narrow cycloalkyl amine scope, we investigated the amine scope of EDDS lyase. Remarkably, EDDS lyase accepted all ten amines as substrates for addition to fumarate, giving high conversions (83-99%) for most reactions (Table 1) . Relatively low conversions were observed for reactions with homocycloalkyl amines 2b and 2e (25% and 10%, respectively) as well as with heterocycloalkyl amines 2h and 2i (14% and 46%, respectively). The enzymatic products were isolated and identified as the anticipated Nsubstituted aspartic acids by 1 H NMR, 13 C NMR and HRMS (see Supporting Information). Hence, EDDS lyase shows a broad amine scope, accepting. structurally distinct homo-and heterocycloalkyl amines in the hydroamination of fumarate. Substrates 2c and 2d were used as racemic mixtures. [b] Reaction conditions: fumaric acid (1, 10 mM), amine 2a-j (100 mM), MgCl 2 (20 mM), and MAL-Q73A (0.1 mol% based on fumaric acid) in H 2 O at pH 9 and room temperature. Reactions were allowed to proceed for 5 d. Conversions were determined using 1 spectroscopy.
H NMR
[c]
The e.e. and d.r. values were determined by chiral HPLC analysis using chemically synthesized reference compounds with known configuration. [d] Reaction conditions: fumaric acid (1, 10 mM), amines 2a-j (100 mM) and EDDS lyase (0.15 mol% based on fumaric acid) in buffer (20 mM NaH 2 PO 4 /NaOH, pH 8.5) at room temperature. Reactions were allowed to proceed for 7 d. Conversions were determined using 1 H NMR spectroscopy.
[e]
The isolated amino acid product could be tentatively assigned the L configuration on the basis of analogy.
[f]
Products 3c and 3d were mixtures of (S,S)-and (S,R)-isomers ( Figure S2 and S3).
[g]
The absolute configuration of product 3j is assigned to be L-trans; Figure S9 ).
The absolute configuration and optical purity of the enzymatic products was determined by HPLC using a chiral stationary phase. For this, N-substituted L-aspartic acids and Nsubstituted D-aspartic acids were prepared by chemical synthesis and used as authentic standards (for detailed procedures, see Supporting Information). The three products from the MAL-Q73A-catalyzed hydroamination reactions (3b, 3e and 3f) were identified as the desired L-configured enantiomers, with >99% enantiomeric excess (e.e.) (Table 1, Figure S1 , S4, S10). Analysis of eight selected products from the EDDS-lyase-catalyzed hydroamination reactions (3b-d, 3f-j) showed that the absolute configuration of the newly formed stereogenic center was L in all cases (>99% e.e., Table 1 , Figure S1 -S9), while no D-configured enantiomers were observed. With regard to amino acid products 3c and 3d, pairs of diastereoisomers (S,S-and S,R-configured) were formed from addition of racemic mixtures of 2c and 2d to fumarate, and the diastereomeric ratio (d.r.) values were determined to be 50:50 ( Figure S2 and S3 ). This revealed that EDDS lyase accepts both enantiomers of the starting racemic substrates 2c or 2d in the hydroamination reactions. Thus, both MAL-Q73A and EDDS lyase exhibit excellent enantioselectivity in the addition of substituted amines to fumarate, yielding the desired optically pure L-aspartic acid derivatives.
To further demonstrate the synthetic usefulness of EDDS-lyase, preparative-scale synthesis of amino acid 3f was performed. Accordingly, substrates 1 (10 mM) and 2f (100 mM) were incubated with EDDS lyase (0.15 mol%) in 20 mM NaH2PO4-NaOH at pH 8.5 and room temperature. Under these conditions, excellent conversion (85%) and good isolated yield (54%, 117 mg) of optically pure (>99% e.e.) product 3f were achieved.
In conclusion, we explored the substrate scope of two C-N lyases, a previously engineered variant of MAL (mutant Q73A) [14, 19] and wild-type EDDS lyase, [21, 22] towards a series of homo-and heterocycloalkyl amines. Pleasingly, EDDS lyase was found to possess broad nonnatural substrate promiscuity accepting various cycloalkyl amines in the hydroamination of fumarate. A set of N-cycloalkyl-substituted L-aspartic acids was synthesized with excellent stereoselectivity (>99% e.e. for all amino acid products), including those with interesting heterocyclic substituents that might allow ring opening and further derivatization for various applications. [30] [31] [32] [33] Previous studies on EDDS lyase revealed that this C-N lyase, when working in reverse, accepts a wide variety of amino acids and diamines as substrates in the hydroamination of fumarate, giving rise to a large number of useful aminocarboxylic acid products, including biodegradable metal chelators and potent metallo-β-lactamase inhibitors. [21, 22] Hence, EDDS lyase is a powerful synthetic tool that nicely complements the rapidly expanding toolbox of biocatalysts for asymmetric synthesis of unnatural amino acids. In contrast to its broad amine scope, EDDS lyase was found to be specific for fumarate, and not capable to accept fumaric acid monomethyl ester, crotonic acid, mesaconic acid, itaconic acid, 2-pentenoic acid or glutaconic acid as alternative substrate for hydroamination. [21] Work is in progress to expand the electrophile scope of EDDS lyase by structure-based protein engineering. 
Supporting Information

Materials and Instrumentation
All reagents that were used to prepare media and buffers were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO) or Merck (Darmstadt, Germany) and were used without further purification. Fumaric acid and the starting amines, 3-aminooxetane, cyclopentylamine, 3-aminotetrahydrofuran, cyclohexylamine, 4-aminotetrahydropyran, 4-aminopiperidine, tetra-2H-thiopyran-3-amine, 1-methyl-4-piperidinamine, and trans-1,4-diaminocyclohexane were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO). Tetrahydrothiophen-3-amine and tetrahydro-2H-thiopyran-4-amine were synthesized according to protocols reported previously. [1, 2] Dowex 50W X8 resin (100-200 mesh) and Dowex 1X8 resin (chloride form, 100-200 mesh) were purchased from Sigma-Aldrich Chemical Co. Ni sepharose 6 fast flow resin and a HiLoad 16/600 Superdex 200 pg column were purchased from GE Healthcare Bio-Sciences AB (Uppsala, Sweden).
NMR analysis was performed on a Brucker 500 MHz machine at the Drug Design laboratory of the University of Groningen. High resolution mass spectrometry (HRMS) was performed by the Mass Spectrometry core facility of the University of Groningen. HPLC analysis was performed on a Shimadzu VP HPLC system. Enzyme purification on a HiLoad 16/600 Superdex 200 pg column was conducted using an AKTAexplorer 10S protein purification system.
General Procedure for Enzymatic Synthesis of N-Cycloalkyl-Substituted
Aspartic Acids
The MAL-Q73A and EDDS lyase enzymes were overproduced and purified to homogeneity by following previously described protocols. [3, 4] For a typical MAL-Q73A reaction, an initial reaction mixture (15 ml) consisting of fumaric acid (0.2 mmol, 200 ul of 1 M stock solution), an amine (2a-2j; 2 mmol), and MgCl2 (0.4 mmol, 400 ul of 1 M stock solution) was prepared in demineralized (demi) water and the pH was adjusted to 9.0. MAL-Q73A (9.6 mg, 0.1 mol% based on fumaric acid) was added to start the reaction, and the volume of the reaction mixture was immediately adjusted to 20 ml with demi water. The reaction was allowed to proceed for 5 d, and was stopped by heating at 70 °C for 10 min. Reaction progress was monitored by 1 H NMR spectroscopy. The conversions were determined by comparing the signals corresponding to fumaric acid (6.5 ppm) and amino acid product.
For a typical EDDS lyase reaction, an initial reaction mixture (15 ml) containing fumaric acid (0.2 mmol, 200 ul of 1 M stock solution) and an amine (2a-2j; 2 mmol) in NaH2PO4-NaOH buffer (20 mM, pH 8.5) was prepared. The pH was adjusted to 8.5 with hydrochloric acid solution. To start the reaction, EDDS lyase (16.5 mg, 0.15 mol% based on fumaric acid) was added, and the final volume of the reaction mixture was immediately adjusted to 20 ml with the same buffer. The reaction was allowed to proceed for 7 d, and stopped by heating at 70 °C for 10 min. The reaction progress was monitored using 1 H NMR spectroscopy by comparing signals corresponding to fumaric acid (6.5 ppm) and amino acid product.
Enzymatic products were purified by two steps of ion-exchange chromatography, as described previously. [3] The purified products were lyophilized and their identity was determined by using 1 H NMR, 13 C NMR and HRMS. The enantiomeric excess and absolute configuration of the product was determined by HPLC analysis on a chiral stationary phase.
N-(3-oxetanyl)aspartic acid (3a)
Synthesis of 3a using EDDS lyase as biocatalyst was performed, and the product was purified according to a slightly modified protocol. The reaction (20 ml , found, 202.1073. The enantiopurity was determined by chiral HPLC analysis on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 1 ml/min at 60°C, detected at 240 nm. Retention time: 13.7 min. , found, 216.1229. The enantiopurity was determined by chiral HPLC analysis on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 1 ml/min at 60°C, detected at 240 nm. Retention time: 13.7 min. , found, 218.1023. The enantiopurity was determined by chiral HPLC analysis on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 1 ml/min at 60°C, detected at 240 nm. Retention time: 6.7 min.
N-[(S/R)-3-tetrahydrofuranyl]-L-aspartic acid (3c)
7
N-[(S/R)-3-tetrahydrothiophenyl]-L-aspartic acid (3d)
N-(4-tetrahydropyranyl)-L-aspartic acid (3f)
MAL
N-(4-piperidinyl)-L-aspartic acid (3g)
29 mg (67% yield); 
General Procedure for Chemical Synthesis of N-Substituted L-or DAspartic Acids
Chemical synthesis of N-substituted L-or D-aspartic acids was performed using a previously described method with a slight modification.
[3] [6] In general, a solution (1 ml) of sodium cyanoborohydride (72.5 mg, 1.15 mmol, 1.5 eq) in dry methanol was added to a mixture of Lor D-aspartic acid (100 mg, 0.75 mmol, 1 eq) and an appropriate ketone/aldehyde (0.90 mmol, 1.2 eq) in dry methanol (2 ml). The mixture was stirred for 24 -48 hours at room temperature. The chiral HPLC analysis was conducted on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 1 ml/min at 60°C, detected at 240 nm. Retention time: 13.8 min.
N-cyclopentyl-D-aspartic acid (D-3b)
The synthesis of compound D-3b was conducted with a slightly modified protocol. Compound D-3b was obtained by reacting cyclopentanone (101 mg, 1.20 mmol) with D-aspartic acid (147 mg, 1.10 mmol) and sodium cyanoborohydride (95.0 mg, 1.50 mmol). The reaction mixture was filtered. The filtrate was evaporated, washed with ethyl acetate (3 x 6 ml), and dried under vacuum. 57 mg product was further purified by silica chromatography (DCM/MeOH: 50:50, v/v).
14 mg (6% yield); The chiral HPLC analysis was conducted on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 1 ml/min at 60°C, detected at 240 nm. Retention time: 6.0 min.
N-[(S/R)-3-tetrahydrofuranyl]-L-aspartic acid [L, (S/R)]-3c
Compound 
N-[(S/R)-3-tetrahydrofuranyl]-D-aspartic acid [D, (S/R)]-3c
Compound D-3c was obtained by reacting dihydrofuran-3(H)-one (73 mg, 0.85 mmol) with D-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72.5 mg, 1.15 mmol). 51 mg (33% yield); 
N-[(S/R)-3-tetrahydrothiophen]-L-aspartic acid [L, (S/R)]-3d
Compound L-3d was obtained by reacting 4.5-dihydro-3(2H)-thiophenone (92 mg, 0.90 mmol) with L-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72. 
N-[(S/R)-3-tetrahydrothiophen]-D-aspartic acid [D, (S/R)]-3d
Compound D-3d was obtained by reacting 4. N-(4-tetrahydro-2H-pyranyl)-L-aspartic acid (L-3f) Compound L-3f was obtained by reacting tetrahydro-4H-pyran-4-one (90 mg, 0.90 mmol) with L-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72. , found, 218.1023. The chiral HPLC analysis was performed on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 1 ml/min at 60°C, detected at 240 nm. Retention time: 6.8 min.
N-(4-tetrahydro-2H-pyranyl)-D-aspartic acid (D-3f)
N-(4-piperidinyl)-L-aspartic acid (L-3g)
Tert-butyl 4-oxo-1-piperidinecarboxylate (179 mg, 0.90 mmol), L-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72.5 mg, 1.15 mmol) were reacted to yield (1-(tert-butoxycarbonyl)piperidin-4-yl)-Laspartic acid (81 mg, 34 % yield). Next, (1-(tert-butoxycarbonyl)piperidin-4-yl)-L-aspartic acid (38 mg, 0.12 mmol) was mixed with water in a closed vial of 4 ml and heated for 20 min at 100 o C. After heating, extra dry ice was added at room temperature, and the heating was continued for 1 h. The compound was purified by flash silica chromatography (gradient elution with dichloromethane/methanol from 50/50 to 10/90) and lyophilized. H NMR of L-3g and enzymatic 3g, L-3g was loaded onto a cation-exchange column (Dowex 50WX8, 100-200 mesh), and eluted in the same way as in the last-step purification of enzymatic 3g (described in previous section). [ 85 (m, 2H) . Chiral HPLC analysis was performed on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 1 ml/min at 60°C, detected at 240 nm. Retention time: 6.4 min.
N-(4-piperidinyl)-D-aspartic acid (D-3g)
Tert-butyl 4-oxo-1-piperidinecarboxylate (179 mg, 0.90 mmol), D-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72.5 mg, 1. 
N-(tetrahydro-2H-thiopyran-4-yl)-L-aspartic acid (L-3h)
Compound L-3h was obtained by reacting tetrahydro-4H-thiopyran-4-one (105 mg, 0.90 mmol) with L-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72.5 mg, 1.15 mmol). 26 mg (15 % yield); The chiral HPLC analysis was performed on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 0.6 ml/min at 60°C, detected at 240 nm. Retention time: 7.1 min. -2H-thiopyran-4-yl)-D-aspartic acid (D-3h) Compound D-3h was obtained by reacting tetrahydro-4H-thiopyran-4-one (105 mg, 0.90 mmol) with D-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72.5 mg, 1.15 mmol). 9 mg (5 % yield); The chiral HPLC analysis was performed on a Nucleosil 5μ chiral-1 120A (250*4.6 mm) column, using isocratic 0.5 mM CuSO4 at 0.6 ml/min at 60°C, detected at 240 nm. Retention time: 5.9 min.
N-(tetrahydro
N-(1-methylpiperidin-4-yl)-L-aspartic acid (L-3i)
Compound L-3i was obtained by reacting N-methyl-piperidone (102 mg, 0.90 mmol) with L-aspartic acid (100 mg, 0.75 mmol) and sodium cyanoborohydride (72. H NMR of L-3g and enzymatic 3g, L-3g was loaded onto a cation-exchange column (Dowex 50WX8, 100-200 mesh), and eluted in the same way as in the last-step purification of enzymatic 3g (descried in previous section). 
N-(cis/trans-4-aminocyclohexyl)-L-aspartic acid [L, (cis/trans)]-3j
Compound L-3j was obtained with a slightly modified protocol. The reaction was started with tert-butyl (4-oxocyclohexyl) 
